109 related articles for article (PubMed ID: 8013973)
1. Plateletpheresis during plasma collection.
Rubertelli M; Marafioti F; Mazzon C; Rossetti G; Gosetti G; Gottardi P; Antolini M; Ceschini N; Boccagni P
Int J Artif Organs; 1993 Dec; 16 Suppl 5():139-42. PubMed ID: 8013973
[TBL] [Abstract][Full Text] [Related]
2. Comparison of platelet-rich plasma collection using the Haemonetics PCS and Baxter Autopheresis C.
Anderson NA; Pamphilon DH; Tandy NJ; Saunders J; Fraser ID
Vox Sang; 1991; 60(3):155-8. PubMed ID: 1862638
[TBL] [Abstract][Full Text] [Related]
3. Platelet collection with the Autopheresis-C apheresis system.
Schoendorfer DW; Williamson LH; Sheckler VL; Fitzgerald BP
Vox Sang; 1990; 58(2):100-5. PubMed ID: 2339518
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of plateletpheresis using Baxter Autopheresis C and Haemonetics PCS plus.
Walton JD; Caffrey EA; Allain JP
Transfus Med; 1994 Mar; 4(1):57-61. PubMed ID: 8012494
[TBL] [Abstract][Full Text] [Related]
5. Plateletpheresis concentrates produced in 30 minutes along with plasma and packed red cells: preliminary results.
Valbonesi M; Frisoni R; Capra C; Lercari G; Fella M; Pittaluga P
J Clin Apher; 1988; 4(4):152-4. PubMed ID: 3220817
[TBL] [Abstract][Full Text] [Related]
6. Haemonetics plasma collection system (PCS): automated collection of platelet-poor or platelet-rich plasma.
Smith JW
J Clin Apher; 1988; 4(2-3):93-6. PubMed ID: 3397375
[TBL] [Abstract][Full Text] [Related]
7. [Mechanical donor plasmapheresis using the Haemonetics Ultralite plasma collection system. 1. Collection of fresh plasma].
Matthes G; Pawlow I; Richter E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):343-8. PubMed ID: 2475417
[TBL] [Abstract][Full Text] [Related]
8. [Collection of thrombocyte concentrates and coagulation active fresh plasma with the Haemonetics PCS system].
Glück D; Koerner K; Stampe D; Kubanek B
Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():16-22. PubMed ID: 3596794
[TBL] [Abstract][Full Text] [Related]
9. Platelet apheresis with Vivacell BT798 DEA, haemonetics V-50 and PCS-Plus: preparation efficiency and product quality using identical donors.
Richter E; Pawlow I; Krause KP; Matthes G
Infusionsther Transfusionsmed; 1992 Oct; 19(5):249-50. PubMed ID: 1288770
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a platelet apheresis technique for the preparation of leukocyte-reduced platelet concentrates.
Zingsem J; Glaser A; Weisbach V; Zimmermann R; Neidhardt B; van Waeg G; Eckstein R
Vox Sang; 1998; 74(3):189-92. PubMed ID: 9595647
[TBL] [Abstract][Full Text] [Related]
11. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
Riggert J; Humpe A; Simson G; Köhler M
Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
[TBL] [Abstract][Full Text] [Related]
12. [Plateletpheresis with the new cell separator A 201 (Baxter)].
Luboldt W; Moog R
Beitr Infusionsther; 1991; 28():195-200. PubMed ID: 1725618
[TBL] [Abstract][Full Text] [Related]
13. Autologous platelet-rich plasma isolated using the Haemonetics Cell Saver 5 and Haemonetics MCS+ for the preparation of platelet gel.
O'Neill EM; Zalewski WM; Eaton LJ; Popovsky MA; Pivacek LE; Ragno G; Valeri CR
Vox Sang; 2001 Oct; 81(3):172-5. PubMed ID: 11703860
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Plateletpheresis on the Haemonetics and Trima Accel Cell Separators.
Keklik M; Keklik E; Kalan U; Ozer O; Arik F; Sarikoc M
Ther Apher Dial; 2018 Feb; 22(1):87-90. PubMed ID: 29082642
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets.
Keklik M; Keklik E; Korkmaz S; Aygun B; Arik F; Kilic O; Sarikoc M
Transfus Apher Sci; 2015 Dec; 53(3):396-8. PubMed ID: 26283175
[TBL] [Abstract][Full Text] [Related]
16. Optimization of platelet concentrate collection for continuous flow cell separation devices (CFCS).
Hester JP; Ventura J
Ann Med Interne (Paris); 1988; 139 Suppl 1():7-10. PubMed ID: 3247996
[TBL] [Abstract][Full Text] [Related]
17. Status of platelet collection and platelet transfusion.
Omokawa S; Notoya T; Kumagai M; Takada G; Watanabe E; Echigoya Y; Saito M; Abe M; Osato N; Kawakami K
Ther Apher; 2001 Feb; 5(1):17-21. PubMed ID: 11258603
[TBL] [Abstract][Full Text] [Related]
18. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of plateletpheresis using Baxter CS 3000 plus and Haemonetics MCS 3P.
Patel AP; Kaur A; Patel V; Patel N; Shah D; Kanvinde S; Prajapati S; Patel H; Rathod D; Adesara R; Rani S
J Clin Apher; 2004; 19(3):137-41. PubMed ID: 15493051
[TBL] [Abstract][Full Text] [Related]
20. Transient inhibition of neutrophil migration following plasma or plasma-platelet apheresis donation procedures.
Ghio M; Bertolotto M; Ottonello L; Contini P; Ubezio G; Tripodi G
Blood Transfus; 2015 Oct; 13(4):682-3. PubMed ID: 25545880
[No Abstract] [Full Text] [Related]
[Next] [New Search]
